Immunology/Inflammation
Read More about this categoryShow Less
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Research Areas
- 5-Lipoxygenase(17)
- Apoptosis(733)
- Cyclic GMP-AMP Synthase(6)
- TLR(123)
- Papain(1)
- PGDS(1)
- PGE synthase(26)
- SIKs(12)
- IκB/IKK(68)
- AP-1(14)
- KEAP1-Nrf2(58)
- NOD1(1)
- NF-κB(310)
- Interleukin Related(291)
- 15-lipoxygenase(2)
- Others(10)
- Aryl Hydrocarbon Receptor(41)
- CD73(17)
- Complement System(71)
- Galectin(12)
- IFNAR(60)
- NO Synthase(94)
- NOD-like Receptor (NLR)(68)
- STING(120)
- Reactive Oxygen Species(519)
- FKBP(15)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(54)
- Adaptive Immunity(210)
- Allergy(118)
- Arthritis(34)
- Autoimmunity(181)
- Gastric Disease(94)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(566)
- Pulmonary Diseases(109)
- Reactive Nitrogen Species(50)
- Specialized Pro-Resolving Mediators(49)
- Reactive Sulfur Species(28)
- BCL6(7)
- CD20(13)
- CD28(4)
- PSMA(14)
- FAP(19)
- Nuclear Factor of activated T Cells (NFAT)(2)
- Glycoprotein VI(2)
- Tim3(4)
- Hapten(1)
- Nectin-4(3)
- DOCK(2)
- MHC(10)
- Transmembrane Glycoprotein(29)
- TREM receptor(11)
- Inflammation or Immune System Disease(2)
- Musculoskeletal and Skin Disease(1)
- Fc Receptor (FcR)(12)
- IKZF Family(4)
- C-type Lectin-like Receptors (CTLRs)(7)
- Asialoglycoprotein Receptor (ASGPR)(3)
- Human leukocyte immunoglobulin (Ig)-like receptors (LILR)(1)
Products Related to Immunology/Inflammation(4566)
- GC79426IFN-α Receptor Recognition Peptide 1 acetatePurity: >99.00%
IFN-α Receptor Recognition Peptide 1 acetate (IRRP1 acetate) is an amino acid synthetic peptide and also a regulator of IFN-α Receptor.
- GC79428Icotrokinra acetatePurity: >99.50%
Icotrokinra (JNJ-77242113) acetate is an orally available, selective antagonist of the IL-23 receptor.
- GC79429Icotrokinra hydrochloridePurity: >99.50%
Icotrokinra (JNJ-77242113) hydrochloride is an orally available, selective antagonist of the IL-23 receptor.
- GC79430Anti-IL11 Antibody (X203, Mouse IgG)Purity: >99.00%
Anti-IL11 Antibody (X203, Mouse IgG ) is an antibody targeting IL-11.
- GC79431UM-259 hydrochloridePurity: >99.00%
UM-259 hydrochloride is a STING inhibitor with activity against both murine and human STING (including the STING R232 mutant).
- GC79432Biotin-labeled ISD sodiumPurity: >91.00%
Biotin-labeled ISD sodium is a biotin-labeled form of ISD sodium.
- GC79434(R)-SARM1-IN-5CAS: 2762081-31-0Purity: >97.50%
(R)-SARM1-IN-5 is the (R)-enantiomer of SARM1-IN-5.
- GC79436(S,S)-SARM1-IN-9CAS: 3020765-70-9Purity: >99.50%
(S,S)-SARM1-IN-9 (Compound MY-13A) is a stereoselective SARM1 inhibitor with covalent binding properties.
- GC79437SARM1-IN-9CAS: 3020765-69-6Purity: >98.00%
SARM1-IN-9 (Compound MY-13B) is a stereoselective SARM1 inhibitor.
- GC79438BazlitoranCAS: 1378549-07-5Purity: >95.00%
Bazlitoran (IMO-8400) is an oligonucleotide-based TLR7/8/9 antagonist.
- GC79439Bazlitoran sodiumCAS: 1613607-40-1Purity: >95.00%
Bazlitoran sodium (IMO-8400 sodium) is an oligonucleotide-based TLR7/8/9 antagonist.
- GC79441Anti-Mouse CD8α Antibody (YTS 105.18)Purity: >99.50%
Anti-Mouse CD8α Antibody (YTS 105.18) is a non-depleting rat IgG2a monoclonal antibody that binds to CD8α on mouse CD8 + T cells.
- GC79442Anti-CD33 Antibody (OR000283)Purity: >99.00%
Anti-CD33 Antibody (OR000283) (ORM-6151 Antibody; BMS-986497 Antibody) is an antibody targeting CD33.
- GC79448Epoetin alfaCAS: 113427-24-0Purity: >98%
Epoetin alfa (Epogen) is a recombinant human erythropoietin whose amino acid sequence and biological activity are identical to those of endogenous erythropoietin (EPO).
- GC79449LifonebartCAS: 3056296-07-9Purity: >99.50%
Lifonebart is a humanized monoclonal antibody targeting TREM2 (triggering receptor expressed on myeloid cells 2).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79426 | IFN-α Receptor Recognition Peptide 1 acetate | - | >99.00% | |
IFN-α Receptor Recognition Peptide 1 acetate (IRRP1 acetate) is an amino acid synthetic peptide and also a regulator of IFN-α Receptor. | ||||
| GC79427 | BP79 | 3104965-33-2 | >98.00% | |
BP79 is a potent TSLP receptor inhibitor. | ||||
| GC79428 | Icotrokinra acetate | - | >99.50% | |
Icotrokinra (JNJ-77242113) acetate is an orally available, selective antagonist of the IL-23 receptor. | ||||
| GC79429 | Icotrokinra hydrochloride | - | >99.50% | |
Icotrokinra (JNJ-77242113) hydrochloride is an orally available, selective antagonist of the IL-23 receptor. | ||||
| GC79430 | Anti-IL11 Antibody (X203, Mouse IgG) | - | >99.00% | |
Anti-IL11 Antibody (X203, Mouse IgG ) is an antibody targeting IL-11. | ||||
| GC79431 | UM-259 hydrochloride | - | >99.00% | |
UM-259 hydrochloride is a STING inhibitor with activity against both murine and human STING (including the STING R232 mutant). | ||||
| GC79432 | Biotin-labeled ISD sodium | - | >91.00% | |
Biotin-labeled ISD sodium is a biotin-labeled form of ISD sodium. | ||||
| GC79433 | NB-3 | 3109123-46-5 | >99.50% | |
NB-3 is a nicotinamide adenine dinucleotide (NAD) hydrolase SARM1 inhibitor. | ||||
| GC79434 | (R)-SARM1-IN-5 | 2762081-31-0 | >97.50% | |
(R)-SARM1-IN-5 is the (R)-enantiomer of SARM1-IN-5. | ||||
| GC79435 | NB-7 | 2665712-31-0 | >99.50% | |
NB-7 is a substituted pyridine derivative and SARM1 inhibitor. | ||||
| GC79436 | (S,S)-SARM1-IN-9 | 3020765-70-9 | >99.50% | |
(S,S)-SARM1-IN-9 (Compound MY-13A) is a stereoselective SARM1 inhibitor with covalent binding properties. | ||||
| GC79437 | SARM1-IN-9 | 3020765-69-6 | >98.00% | |
SARM1-IN-9 (Compound MY-13B) is a stereoselective SARM1 inhibitor. | ||||
| GC79438 | Bazlitoran | 1378549-07-5 | >95.00% | |
Bazlitoran (IMO-8400) is an oligonucleotide-based TLR7/8/9 antagonist. | ||||
| GC79439 | Bazlitoran sodium | 1613607-40-1 | >95.00% | |
Bazlitoran sodium (IMO-8400 sodium) is an oligonucleotide-based TLR7/8/9 antagonist. | ||||
| GC79440 | ENDO12 | - | >98% | |
ENDO12 is an inhibitor of the Munc13-4-STX7 protein complex, with a K d value of 2.7 µM for STX7. | ||||
| GC79441 | Anti-Mouse CD8α Antibody (YTS 105.18) | - | >99.50% | |
Anti-Mouse CD8α Antibody (YTS 105.18) is a non-depleting rat IgG2a monoclonal antibody that binds to CD8α on mouse CD8 + T cells. | ||||
| GC79442 | Anti-CD33 Antibody (OR000283) | - | >99.00% | |
Anti-CD33 Antibody (OR000283) (ORM-6151 Antibody; BMS-986497 Antibody) is an antibody targeting CD33. | ||||
| GC79443 | PY265 | - | >95.00% | |
PY265 is an anti-human MARCO IgG antibody. | ||||
| GC79444 | EP 80317 acetate | - | >99.00% | |
EP 80317 acetate is a selective CD36 ligand. | ||||
| GC79445 | AE105 | 254729-66-3 | >99.50% | |
AE105 is a 9-mer peptide probe targeting the urokinase-type plasminogen activator receptor ( uPAR ). | ||||
| GC79446 | EP9 | - | >99.50% | |
EP9 is a peptide targeting CD63. | ||||
| GC79447 | FB102 | - | >99.00% | |
FB102 is an anti-human CD122 (IL-2Rβ) monoclonal antibody with selective activity. | ||||
| GC79448 | Epoetin alfa | 113427-24-0 | >98% | |
Epoetin alfa (Epogen) is a recombinant human erythropoietin whose amino acid sequence and biological activity are identical to those of endogenous erythropoietin (EPO). | ||||
| GC79449 | Lifonebart | 3056296-07-9 | >99.50% | |
Lifonebart is a humanized monoclonal antibody targeting TREM2 (triggering receptor expressed on myeloid cells 2). | ||||
